Karyopharm Therapeutics Inc (NASDAQ: KPTI) stock jumped 0.91% on Monday to $0.79 against a previous-day closing price of $0.78. With 0.88 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.23 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.8222 whereas the lowest price it dropped to was $0.7600. The 52-week range on KPTI shows that it touched its highest point at $5.41 and its lowest point at $0.67 during that stretch. It currently has a 1-year price target of $5.50. Beta for the stock currently stands at -0.17.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of KPTI was up-trending over the past week, with a rise of 5.04%, but this was down by -25.75% over a month. Three-month performance dropped to -46.46% while six-month performance fell -68.89%. The stock lost -85.04% in the past year, while it has lost -76.85% so far this year. A look at the trailing 12-month EPS for KPTI yields -1.32 with Next year EPS estimates of -0.87. For the next quarter, that number is -0.27. This implies an EPS growth rate of 43.94% for this year and 22.90% for next year.
Float and Shares Shorts:
At present, 113.21 million KPTI shares are outstanding with a float of 106.41 million shares on hand for trading. On Oct 30, 2023, short shares totaled 17.91 million, which was 15.64% higher than short shares on Sep 28, 2023. In addition to Mr. Richard A. Paulson M.B.A. as the firm’s President, CEO & Director, Dr. Sharon Shacham M.B.A., Ph.D. serves as its Co-Founder & Chairman of Scientific Advisory Board.
Institutional Ownership:
Through their ownership of 73.63% of KPTI’s outstanding shares, institutional investors have majority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for KPTI since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With KPTI analysts setting a high price target of $10.00 and a low target of $3.00, the average target price over the next 12 months is $5.50. Based on these targets, KPTI could surge 1165.82% to reach the target high and rise by 279.75% to reach the target low. Reaching the average price target will result in a growth of 596.2% from current levels.
Summary of Insider Activity:
Insiders traded KPTI stock several times over the past three months with 1 Buys and 6 Sells. In these transactions, 41,140 shares were bought while 25,427 shares were sold. The number of buy transactions has increased to 8 while that of sell transactions has risen to 30 over the past year. The total number of shares bought during that period was 813,140 while 152,002 shares were sold.
